Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Pieber, TR; Aronson, R; Christiansen, MP; Bode, B; Junaidi, K; Conoscenti, V.
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes.
Diabetes Obes Metab. 2022; 24(7):1394-1397 Doi: 10.1111/dom.14699
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Pieber Thomas
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (using NLM MeSH Indexing)
Adult - administration & dosage
Blood Glucose - administration & dosage
Diabetes Mellitus, Type 1 - drug therapy
Glucagon - adverse effects
Humans - administration & dosage
Hypoglycemia - chemically induced, prevention & control
Hypoglycemic Agents - adverse effects
Insulin - adverse effects
Temperature - administration & dosage

Find related publications in this database (Keywords)
glucagon
severe hypoglycaemia
type 1 diabetes
© Med Uni Graz Impressum